Target intelligence / Profile preview

Ribosomal protein L15 pseudogene 20 (RPL15P20)

Target
RPL15P20
Molecular classification
Other (Pseudogene)
01

Overview

Ribosomal protein L15 pseudogene 20 (RPL15P20) is a nonfunctional, processed pseudogene related to the ribosomal protein L15 gene (RPL15) in humans[4]. The RPL15 gene encodes a protein that is a component of the 60S large ribosomal subunit and is involved in protein synthesis in the cytoplasm[1][2][3]. However, RPL15P20 itself does not encode a functional protein, and as a pseudogene, it is not considered a protein-coding gene, enzyme, receptor, transporter, or therapeutic target. It has no known biological function, disease association, or relevance in drug discovery or as a biomarker. Pseudogenes such as RPL15P20 are common in the human genome and arise from duplication or retrotransposition events but no longer produce a functional product[4]. Key points: - RPL15P20 is a processed pseudogene, not an active protein, enzyme, or therapeutic target. - It does not play a known biological or pathological role, nor is it relevant for drug discovery or therapeutics. - Its entry as a target is incorrect in the context of pharmacological or biomedical targeting. If you require information on the functional, protein-coding RPL15 (Ribosomal protein L15), which does play roles in ribosome biogenesis and cancer biology, this is a distinct entity (RPL15, not RPL15P20)[1][2][3].

Other names
RPL15_7_1476RPL15P20

Beyond the preview

Go deeper on Ribosomal protein L15 pseudogene 20 (RPL15P20).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L15 pseudogene 20 (RPL15P20).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call